KeyBanc Hikes Arm Holdings Price Target to $430

1 min read Reproduced verbatim
Rating
Overweight
Target
$430
from $300 (+43%)
Upside
+115%
ARM at $200 today
KeyBanc and Arm logos

What the analyst said

KeyBanc analyst John Vinh raised the price target on Arm Holdings (NASDAQ: ARM) to $430 (from $300) while maintaining an Overweight rating.

Disclaimer
The price target and rating on this page are the opinion of the issuing research firm and its analyst, not of Price Target. This page is published for informational purposes only and is not investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consider your own circumstances and consult a licensed financial adviser before making investment decisions.

This research note is reproduced verbatim from the issuing firm. Price Target never edits, paraphrases or alters analysts’ words — we only republish them in one place.

Where the price stands

ARM trades at $200. The 2 analysts who set a target in the last 3 months range from $320 to $641, with a median of $481. This $430 target is 11% below the median.

Since the note ARM has moved −33% (from $299). 12-month window: day 111 of 365, closes on July 14, 2027.

Track record

This callOpen: ARM has not reached $430 yet. This 12-month target is scored on July 14, 2027.

Firm track recordKeyBanc: 79% of its 24 targets at least a year old were reached within 12 months (#12 of 26 firms). Accuracy ranking →

KeyBanc on Arm

KeyBanc price targets on Arm

3 calls from February 5, 2026 to July 14, 2026. The target went from $170 to $430 (+153%). The rating stayed Buy.

KeyBanc targetARM share price
  1. July 14, 2026 This noteTarget raised from $300 (+43%)Buy$430
  2. May 7, 2026Target raised from $170 (+76%)Buy$300
  3. February 5, 2026Earliest call shownBuy$170
Share
Share on
Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.